Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.

Carteolol

Подписчиков: 0, рейтинг: 0
Carteolol
Carteolol skeletal.svg
Clinical data
Trade names Ocupress
AHFS/Drugs.com Professional Drug Facts
MedlinePlus a601078
License data
Routes of
administration
Eye drops
ATC code
Legal status
Legal status
  • US: ℞-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability 85%
Metabolism Liver, active with 8-hydrocarteolol
Elimination half-life 6–8 hours
Excretion Kidney (50-70%)
Identifiers
  • (RS)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2(1H)-one
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C16H24N2O3
Molar mass 292.379 g·mol−1
3D model (JSmol)
Chirality Racemic mixture
  • O=C2Nc1cccc(OCC(O)CNC(C)(C)C)c1CC2
  • InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20) checkY
  • Key:LWAFSWPYPHEXKX-UHFFFAOYSA-N checkY
  (verify)

Carteolol is a non-selective beta blocker used to treat glaucoma.

It has been found to act as a serotonin 5-HT1A and 5-HT1B receptor antagonist in addition to being a beta blocker.

It was patented in 1972 and approved for medical use in 1980.

Brand names

  • Arteolol
  • Arteoptic
  • Calte
  • Cartéabak
  • Carteol
  • Cartéol
  • Cartrol
  • Elebloc
  • Endak
  • Glauteolol
  • Mikelan
  • Ocupress
  • Poenglaucol
  • Teoptic
  • Singlauc

Further reading

  • El-Kamel A, Al-Dosari H, Al-Jenoobi F (2006). "Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride". Drug Delivery. 13 (1): 55–59. doi:10.1080/10717540500309073. PMID 16401594. S2CID 30222292.
  • Kuwahara K, Oizumi N, Fujisawa S, Tanito M, Ohira A (March 2005). "Carteolol hydrochloride protects human corneal epithelial cells from UVB-induced damage in vitro". Cornea. 24 (2): 213–220. doi:10.1097/01.ico.0000141232.41343.9d. PMID 15725891. S2CID 20523541.
  • Trinquand C, Romanet JP, Nordmann JP, Allaire C (February 2003). "[Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]". Journal Francais d'Ophtalmologie. 26 (2): 131–136. PMID 12660585.

Новое сообщение